D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
DNTH holding history
Dianthus Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DNTH overviewAll 13F holders of DNTHFull Q2 2026 holdings
- Shares (Q2 2026)
- 42,928
- Value
- $4.18M
- % of portfolio
- <0.1%
- Quarters held
- 6
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 42,928 | $4.18M | <0.1% | −106,681−71.3% | Reduced | Holders |
| Q1 2026 | 149,609 | $12.6M | <0.1% | −5,069−3.3% | Reduced | Holders |
| Q4 2025 | 154,678 | $6.37M | <0.1% | +123,064+389.3% | Added | Holders |
| Q3 2025 | 31,614 | $1.24M | <0.1% | +31,614 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −53,026−100.0% | Sold out | Holders |
| Q2 2022 | 53,026 | $64.0K | <0.1% | +35,035+194.7% | Added | Holders |
| Q1 2022 | 17,991 | $52.0K | <0.1% | +17,991 | New | Holders |